Recombinant multi-species CHST7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHST7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the Gal/GalNAc/GlcNAc (galactose/N-acetylgalactosamine/N-acetylglucosamine) 6-O-sulfotransferase (GST) family. Members of this family encode enzymes that catalyze the specific addition of sulfate groups to distinct hydroxyl and amino groups of carbohydrates. The encoded protein catalyzes the sulfation of 6-hydroxyl group of GalNAc in chondroitin. [provided by RefSeq, Aug 2013]
The Alternative Names of target: 2600013M07Rik,C6ST-2,CHST7,Carbohydrate sulfotransferase 7,Chondroitin 6-sulfotransferase 2 (C6ST-2),Chst7,GST-5,GST5,Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5 (GST-5),Gn6st-4,Gn6st-4),N-acetylglucosamine 6-O-sulfotransferase 4 (GlcNAc6ST-4,glcNAc6ST-4
Go
to CHST7 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0087-Ag-1/ GM-Tg-hg-SE0087-Ag-2 | Human CHST7 protein | Human |
| GM-Tg-rg-SE0087-Ag-1/ GM-Tg-rg-SE0087-Ag-2 | Rat CHST7 protein | Rat |
| GM-Tg-mg-SE0087-Ag-1/ GM-Tg-mg-SE0087-Ag-2 | Mouse CHST7 protein | Mouse |
| GM-Tg-cynog-SE0087-Ag-1/ GM-Tg-cynog-SE0087-Ag-2 | Cynomolgus/Rhesus macaque CHST7 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0087-Ag-1/ GM-Tg-felg-SE0087-Ag-2 | Feline CHST7 protein | Feline |
| GM-Tg-cang-SE0087-Ag-1/ GM-Tg-cang-SE0087-Ag-2 | Canine CHST7 protein | Canine |
| GM-Tg-bovg-SE0087-Ag-1/ GM-Tg-bovg-SE0087-Ag-2 | Bovine CHST7 protein | Bovine |
| GM-Tg-equg-SE0087-Ag-1/ GM-Tg-equg-SE0087-Ag-2 | Equine CHST7 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0087-Ag-1/ GM-Tg-hg-SE0087-Ag-2;
GM-Tg-rg-SE0087-Ag-1/ GM-Tg-rg-SE0087-Ag-2;
GM-Tg-mg-SE0087-Ag-1/ GM-Tg-mg-SE0087-Ag-2; GM-Tg-cynog-SE0087-Ag-1/ GM-Tg-cynog-SE0087-Ag-2; GM-Tg-felg-SE0087-Ag-1/ GM-Tg-felg-SE0087-Ag-2; GM-Tg-cang-SE0087-Ag-1/ GM-Tg-cang-SE0087-Ag-2; GM-Tg-bovg-SE0087-Ag-1/ GM-Tg-bovg-SE0087-Ag-2; GM-Tg-equg-SE0087-Ag-1/ GM-Tg-equg-SE0087-Ag-2 |
| Products Name | CHST7 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CHST7 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHST7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.